L. Roy Papp & Associates’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.06M Buy
+70,700
New +$1.7M 0.11% 93

Other funds holding RARE

L. Roy Papp & Associates's RARE Position: Q3 2026 in Review

L. Roy Papp & Associates opened a new position in Ultragenyx Pharmaceutical (RARE) in Q3 2026: 70,700 shares worth $1.06M. The stake represents 0.11% of the portfolio and ranks #93 among its holdings.

186 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • L. Roy Papp & Associates held 70,700 shares of Ultragenyx Pharmaceutical worth $1.06M as of Q3 2026.
  • Ultragenyx Pharmaceutical was a new L. Roy Papp & Associates position in Q3 2026.
  • Ultragenyx Pharmaceutical made up 0.11% of L. Roy Papp & Associates's portfolio in Q3 2026, its #93 holding.
  • 186 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on L. Roy Papp & Associates's 13F filing for Q3 2026, filed 21 Oct 2026.